Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Daiichi Sankyo
Teva
Merck
UBS
Moodys
Healthtrust
Boehringer Ingelheim
AstraZeneca
Medtronic

Generated: January 18, 2018

DrugPatentWatch Database Preview

CIPROFLOXACIN HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Ciprofloxacin Hydrochloride patents expire, and what generic alternatives are available?

Ciprofloxacin Hydrochloride is a drug marketed by Akorn Inc, Amring Pharms, Apotex Inc, Fdc Ltd, Rising Pharms Inc, Teligent, Watson Labs Inc, Apotex, Aurobindo Pharma, Barr, Carlsbad, Dr Reddys Labs Ltd, Hikma, Idt Australia Ltd, Ivax Sub Teva Pharms, Mylan, Nostrum Labs, Pliva, Sandoz, Sun Pharm Inds Ltd, Taro Pharm, Teva, Unique Pharm Labs, and Watson Labs. and is included in twenty-five NDAs.

The generic ingredient in CIPROFLOXACIN HYDROCHLORIDE is ciprofloxacin hydrochloride. There are thirty-one drug master file entries for this compound. Seventy-four suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the ciprofloxacin hydrochloride profile page.
Drug patent expirations by year for CIPROFLOXACIN HYDROCHLORIDE
Pharmacology for CIPROFLOXACIN HYDROCHLORIDE
Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial

US Patents and Regulatory Information for CIPROFLOXACIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nostrum Labs CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076138-001 Jun 9, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076089-003 Jun 9, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076593-003 Jun 9, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076136-003 Jun 9, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pliva CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076426-002 Jun 15, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076593-004 Jun 9, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro Pharm CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076912-002 Oct 6, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Unique Pharm Labs CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076639-001 Sep 10, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Idt Australia Ltd CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 075939-002 Jun 9, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076089-004 Jun 9, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Cipla
Deloitte
AstraZeneca
Julphar
Chubb
Moodys
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot